Q+A with Svelland Capital, 2022 Deal Highlights & Propel(x)'s Holiday Reading List

This newsletter begins with some of 2022’s deal highlights on the Propel(x) platform. If you want to invest in similar deals or build a curated, inbound deal flow on auto-pilot, create a free account on Propel(x) today.

We are proud to share that Propel(x)'s recent offering - Svelland Global Trading Fund took the top spot in this year’s list of best-performing Nordic hedge funds. First tranche has already closed. Second tranche closing on Propel(x) in Q1 2023. Pledge interest in Svelland Capital today.

Additionally, with Assure shutting down, we are now offering our in-house SPV Management services to others who are looking to transition away from their current service provider or create new SPVs. Extending this further, our CEO - Swati Chaturvedi speaks extensively about SPVs and syndicates in her latest podcast episode with Shawn Flynn, Host of the Silicon Valley Podcast.

This holiday season we bring you the gift of education. Instead of sharing gift lists sourced off of the internet, we thought to share a holiday reading list from Propel(x). We have shared key articles under four categories - Thought Leadership, Investor Education, Deal Spotlight and Platform Spotlight. With the tax season approaching soon, we have specifically shared blog posts and webinar replays on Qualified Small Business Stock and other tax benefits for investors in startups.

A farewell 2022 letter from our CEO summarizing the year including key portfolio updates will be posted next week on our blog.

Stay tuned and enjoy the scroll down. Happy Holidays!

Decent Health* is on a mission to offer affordable healthcare for everyone, with solutions designed for small businesses and the self-employed to obtain health insurance at below market rates. The company closed a Series A round on Propel(x) in February 2022 as part of a wider capital raising that according to Crunchbase totaled $18m. Propel(x) investors invested alongside notable institutional investors such as Menlo Ventures, QED, Foundation Capital, and Sequoia Capital.

ChEmpower* is an advanced materials and specialized chemistry start-up whose products help those in the semiconductor manufacturing industry increase yield, reduce cost, and preserve the environment. ChEmpower closed a Series Seed round on Propel(x) in April 2022 as part of a $4m financing round led by Intel Capital.

Cyberdontics* is a surgical robotics startup that is developing robots to automate restorative dentistry, starting with dental crowns and then with plans to progress to fillings. Cyberdontics closed a Pre-Series A round on Propel(x) in January 2022 as part of a wider capital raise that Crunchbase says totals $19.3m. Notable institutional investors involved in the Cyberdontics raise include Y-Combinator and C3 Ventures.

TaskHuman* helps users discover and connect with a global network of specialists in personal and professional wellbeing and growth. TaskHuman closed a Series B round on Propel(x) in June 2022, with data from Crunchbase showing TaskHuman has raised a total of $33m. Propel(x) investors participated alongside notable institutional investors such as Madrona Venture Group, USVP, Impact Venture Capital, and Zoom.

For those of you who regularly invest via special purpose vehicles, either through Propel(x) or through other channels, you may have heard that Assure Services, one of the largest SPV providers in the country, decided to wind down operations and will no longer support its customers.

Propel(x) offers affordable and reliable fund management services through Planck Fund Management Corporation.

If you've ever participated through an SPV as an investor, please contact your SPV manager and introduce them to Propel(x) via the spvs@propelx.com

Shawn Flynn, Host of the Silicon Valley Podcast sat down with our CEO where they talk about SPVs, syndicates, Propel(x)'s due diligence capabilities, our expansion in Asia and much more.

This video podcast episode covers

- What is a schedule K-1 for SPVs?
- What are some terms or vocabulary that people seem confused about when looking at early-stage and syndicates?
- How do angel groups and Venture Capitalists use and work with syndicates?
- Changes in the Silicon Valley Investment landscape that occurred over the pandemic?
- How should a company line up milestones with their funding strategy?